Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
09.02.26
/
50%
€164.40
Target price
09.02.27
-
Performance (%)
-6.95%
Price
15.04.26
€152.98
Summary
This prediction is currently active. With a performance of -6.95%, the BUY prediction for Biogen Inc. by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 09.02.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.791% | -0.791% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat